Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
TG Therapeutics, Inc.
Scientific Title
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma